Understanding the Structure of Module 2.7: Clinical Summary Simplified

σε πρόσθεσε στο Health

2025-07-01 06:14:55 -

In medicinal Product (drug) development and Regulatory submissions, one component that can significantly influence the speed and success of approval is the Clinical Summary—or Module 2.7—within the Common Technical Document (CTD). Whether you're submitting a New Drug Application (NDA) to the FDA, a Marketing Authorization Application (MAA) to the EMA, or a Global Dossier under ICH...

0 Σχόλια 0 Μοιράστηκε 897 Views 0 Προεπισκόπηση